Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Here’s Why Sunrun (RUN) Stock Is Trading Lower

SunPower Corp (NASDAQ: SPWR) shares are trading lower by 5.95% to $20.06 during Wednesday's session. Shares of several solar stocks are trading lower in sympathy with Enphase Energy, which reported worse-than-expected Q1 sales and issued weak Q2 guidance.
byHenry Khederian
April 26, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SunPower Corp (NASDAQ:SPWR) shares are trading lower by 5.95% to $20.06 during Wednesday’s session. Shares of several solar stocks are trading lower in sympathy with Enphase Energy, which reported worse-than-expected Q1 sales and issued weak Q2 guidance.

Additionally, Enphase received a number of analyst rating updates following the first-quarter print.

What Happened?

Enphase Energy reported quarterly earnings of $1.37 per share, which beat the analyst consensus estimate of $1.20.

The company also reported quarterly sales of $726.02 million, which missed the analyst consensus estimate of $732.30 million by roughly 1%. This sales figure is, however, a marked 64.5% percent increase over sales of $441.29 million in the same period last year…Read More

See Also: Awaiting Q1 GDP Results: Can US Economy Fend Off Recession Fears?

According to data from Benzinga Pro, RUN has a 52-week high of $39.13 and a 52-week low of $16.69.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms

By Jelena Martinovic
June 20, 8:59 AM
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Thursday its financial and operational results for the fourth quarter and fiscal year 2024.The company reported a 5% year-over-year increase in revenue to CA$67.4 million ($49.1 million) in the fourth quarter. Global medical cannabis net revenue grew by 20% over the same period to CA$45.6 million. The increase in net revenue1 of $7.7 million was primarily due to higher sales to Australia and Europe in the current period following the success of newly launched innovative cultivars in these markets. 

ACB